RPRX logo

Royalty Pharma Plc (RPRX)

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, in...

NASDAQHealthcareBiotechnologyUSA

Company Profile

Stock Code
RPRX
ISIN Code
GB00BMVP7Y09
Currency
US Dollar (USD)
IPO Date
1993-03-25

Contact Information

Company Address
110 East 59th Street, New York, NY, United States, 10022
Contact Phone
212 883 0200
Company Website
https://www.royaltypharma.com
Fiscal Year End
December

Financial Highlights

Market Capitalization
$999,999.99
Gross Profit (TTM)
$999,999.99
Dividend Yield
1.42%
Return on Assets (TTM)
5.09%
EBITDA
$999,999.99
Revenue (TTM)
$999,999.99